Close Menu
    What's Hot

    Equity Release Missing From Retirement Planning Conversations

    January 22, 2026

    Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

    January 22, 2026

    Majority of UK DB Pension Members Open To Run-On

    January 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      Majority of UK DB Pension Members Open To Run-On

      January 22, 2026

      Dr. Martens Airwair Group Pension Plan Completes Bulk Purchase Annuity Buy-In With PIC

      January 22, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      Majority of UK DB Pension Members Open To Run-On

      January 22, 2026

      Dr. Martens Airwair Group Pension Plan Completes Bulk Purchase Annuity Buy-In With PIC

      January 22, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      Majority of UK DB Pension Members Open To Run-On

      January 22, 2026

      Dr. Martens Airwair Group Pension Plan Completes Bulk Purchase Annuity Buy-In With PIC

      January 22, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      Majority of UK DB Pension Members Open To Run-On

      January 22, 2026

      Dr. Martens Airwair Group Pension Plan Completes Bulk Purchase Annuity Buy-In With PIC

      January 22, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      Majority of UK DB Pension Members Open To Run-On

      January 22, 2026

      Dr. Martens Airwair Group Pension Plan Completes Bulk Purchase Annuity Buy-In With PIC

      January 22, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      Majority of UK DB Pension Members Open To Run-On

      January 22, 2026

      Dr. Martens Airwair Group Pension Plan Completes Bulk Purchase Annuity Buy-In With PIC

      January 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025

      Editor’s Letter – Volume 4, Issue 9, September 2025

      September 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: William Corry, Founder and Managing Director, Corry Capital Advisors

    Secondary Life Markets August 10, 2023By Greg Winterton
    Share
    Twitter LinkedIn Email

    Life settlement investor Corry Capital Advisors manages more than $2bn in assets and counts pension plans, foundations, endowments, and sovereign wealth funds amongst its clients. Greg Winterton spoke to William Corry, Founder and Managing Director at Corry Capital Advisors, to get his views on the industry, and to learn more about the firm and its approach. 

    GW: Bill, a lot has been made of the impact of higher interest rates on investor appetite for life settlements, but there’s some cyclicality here, isn’t there? Are there any reasons why investors should still be allocating now versus waiting for rates to plateau, or come down? 

    WC: I understand the discussion regarding higher interest rates vs life settlement investing, however the case for consistency of investing in diversified products, especially those that are to a large degree not correlated to markets, continues to make the case for life settlements to be considered for investors. 

    GW: In a Life Risk News roundtable in February this year, you mentioned that you saw wealth managers taking an increased interest in the life settlement space last year. Is that a trend that’s continued in the first half of this year, and if so, what are the drivers? 

    WC: I continue to see that as a trend, and I believe the driver is advisors continuing to look into non-corelated investment opportunities. 

    GW: Moving onto your firm. What do you look for in a policy when you’re evaluating policies in the secondary market, and why? 

    WC: In the secondary market the evaluation beyond pricing is driven by due diligence into the chain of title and origination of the policy. Origination being driven by insurable interest correctly being established at time of purchase. 

    GW: Corry Capital Advisors is also active in the industry’s tertiary market. Discounts in this space have been hard to come by in recent years. Has anything changed this year so far, and if so, what’s driving that? 

    WC: There are several factors that affect the discounts on tertiary policies and portfolios. If the seller is distressed, then the discount rates are typically higher, as well as if you’re dealing directly with the capital source vs going through intermediaries, as that can add a large amount of fees that reduce the discount rate. This year there has been an increase in tertiary portfolios in the market, which is a positive trend on the buy side. 

    GW: Finally, Bill, what’s your message to investors when conducting due diligence on a life settlement fund manager? What are a couple of specifics that they should focus on? 

    WC: Factors that should be considered would be conducting background checks on the manager and senior management as well as researching track record of past funds and the transparency supporting the track record. I think investors should dig down deep into the transparency of a past fund’s performance to the point of evaluating the granular investments to see how they’ve performed over time. The realised events are easy to evaluate, though the unrealised are being driven by different factors, such as medical updates and the valuation methodology of the manager when it comes to the marks of each policy. 

    2023 - August Life Settlements Longevity Risk Q&A Volume 2 Issue 8 - August 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Equity Release Missing From Retirement Planning Conversations

    January 22, 2026By LMI Newsdesk

    Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

    January 22, 2026By LMI Newsdesk

    Majority of UK DB Pension Members Open To Run-On

    January 22, 2026By LMI Newsdesk

    Dr. Martens Airwair Group Pension Plan Completes Bulk Purchase Annuity Buy-In With PIC

    January 22, 2026By LMI Newsdesk
    Latest Issue

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.